Answers are grounded in this paper and cite their sources.
Meta-analysis reveals reduced risk of gastrointestinal and reproductive cancers with aspirin use, suggesting broad chemopreventive effects.
These findings suggest that aspirin use is associated with a reduced risk of gastric, esophageal, colorectal, pancreatic, ovarian, endometrial, breast, and prostate cancers, and small intestine neuroendocrine tumors.
No takes yet. Share an insight, caveat, or question.
Qiao et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: